CTI BioPharma Corp.

5.41-0.2600-4.59%Vol 6.72M1Y Perf 114.77%
Aug 16th, 2022 16:00 DELAYED
BID5.39 ASK5.41
Open5.72 Previous Close5.67
Pre-Market- After-Market5.48
 - -  0.07 1.29%
Target Price
8.30 
Analyst Rating
Strong Buy 1.20
Potential %
53.42 
Finscreener Ranking
     34.42
Insiders Trans % 3/6/12 mo.
-100/-100/-76 
Value Ranking
+     34.63
Insiders Value % 3/6/12 mo.
-100/-100/-99 
Growth Ranking
     25.22
Insiders Shares Cnt. % 3/6/12 mo.
-100/-100/-97 
Income Ranking
 —    -
Price Range Ratio 52W %
62.48 
Earnings Rating
Strong Buy
Market Cap618.82M 
Earnings Date
8th Aug 2022
Alpha0.04 Standard Deviation0.31
Beta0.88 

Today's Price Range

5.375.72

52W Range

1.437.80

5 Year PE Ratio Range

-1.90-3.50

Summary:

Sell

Technical Indicators: Sell
Moving Averages: Sell
Performance
1 Week
-9.98%
1 Month
-17.66%
3 Months
22.95%
6 Months
140.44%
1 Year
114.77%
3 Years
732.31%
5 Years
73.40%
10 Years
-73.61%

TickerPriceChg.Chg.%
CTIC5.41-0.2600-4.59
AAPL173.03-0.1600-0.09
GOOG122.51-0.3700-0.30
MSFT292.71-0.7600-0.26
XOM91.46-0.8600-0.93
WFC46.060.31000.68
JNJ167.571.48000.89
FB196.640.99000.51
GE81.071.26001.58
JPM123.631.17000.96
 
ProfitabilityValueIndustryS&P 500US Markets
91.80
-770.40
-762.50
-551.90
-
RevenueValueIndustryS&P 500US Markets
14.62M
0.13
-54.98
-37.25
Earnings HistoryEstimateReportedSurprise %
Q02 2022-0.20-0.21-5.00
Q01 2022-0.35-0.37-5.71
Q04 2021-0.28-0.38-35.71
Q03 2021-0.22-0.26-18.18
Q02 2021-0.20-0.21-5.00
Q01 2021-0.20-0.23-15.00
Q04 2020-0.16-0.20-25.00
Q03 2020--0.15-
Earnings Per EndEstimateRevision %Trend
6/2022 QR-0.2218.52Positive
9/2022 QR-0.1433.33Positive
12/2022 FY-0.84-25.37Negative
12/2023 FY0.28-9.68Negative
Next Report Date-
Estimated EPS Next Report-0.20
Estimates Count3
EPS Growth Next 5 Years %-
Volume Overview
Volume6.72M
Shares Outstanding114.39K
Shares Float99.81M
Trades Count25.63K
Dollar Volume36.58M
Avg. Volume5.95M
Avg. Weekly Volume8.45M
Avg. Monthly Volume4.60M
Avg. Quarterly Volume4.81M

CTI BioPharma Corp. (NASDAQ: CTIC) stock closed at 5.41 per share at the end of the most recent trading day (a -4.59% change compared to the prior day closing price) with a volume of 6.72M shares and market capitalization of 618.82M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 25 people. CTI BioPharma Corp. CEO is Adam R. Craig.

The one-year performance of CTI BioPharma Corp. stock is 114.77%, while year-to-date (YTD) performance is 118.15%. CTIC stock has a five-year performance of 73.4%. Its 52-week range is between 1.43 and 7.8, which gives CTIC stock a 52-week price range ratio of 62.48%

CTI BioPharma Corp. currently has a PE ratio of -4.70, a price-to-book (PB) ratio of 112.63, a price-to-sale (PS) ratio of 44.35, a price to cashflow ratio of -, a PEG ratio of 2.32, a ROA of -113.94%, a ROC of -145.66% and a ROE of -428.11%. The company’s profit margin is -%, its EBITDA margin is -762.50%, and its revenue ttm is $14.62 Million , which makes it $0.13 revenue per share.

Of the last four earnings reports from CTI BioPharma Corp., there were 0 positive earnings surprise and 4 negative earnings surprise. The company has EPS estimate of $-0.20 for the next earnings report. CTI BioPharma Corp.’s next earnings report date is -.

The consensus rating of Wall Street analysts for CTI BioPharma Corp. is Strong Buy (1.2), with a target price of $8.3, which is +53.42% compared to the current price. The earnings rating for CTI BioPharma Corp. stock is Strong Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

CTI BioPharma Corp. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

CTI BioPharma Corp. has a Sell technical analysis rating based on Technical Indicators (ADX : 11.91, ATR14 : 0.61, CCI20 : -128.86, Chaikin Money Flow : 0.03, MACD : -0.03, Money Flow Index : 38.23, ROC : -11.68, RSI : 36.32, STOCH (14,3) : 9.75, STOCH RSI : 0.01, UO : 47.25, Williams %R : -90.25), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of CTI BioPharma Corp. in the last 12-months were: Adam R. Craig (Buy at a value of $5 337), Adam R. Craig (Option Excercise at a value of $60 747), Adam R. Craig (Sold 72 223 shares of value $435 343 ), David H. Kirske (Option Excercise at a value of $184 489), David H. Kirske (Sold 70 000 shares of value $427 505 ), Michael Metzger (Option Excercise at a value of $76 961), Michael Metzger (Sold 111 221 shares of value $684 450 )

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
4 (80.00 %)
4 (80.00 %)
3 (75.00 %)
Moderate Buy
1 (20.00 %)
1 (20.00 %)
1 (25.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingStrong Buy
1.20
Strong Buy
1.20
Strong Buy
1.25

CTI BioPharma Corp.

CTI BioPharma Corp is a biopharmaceutical company focused on the acquisition, development, and commercialization of less toxic and more effective cancer therapies. The company's therapeutic area is blood-related cancers. Its products under pipeline include PIXUVRI, and Pacritinib. PIXUVRI is a novel aza-anthracenedione with unique structural and physiochemical properties. Pacritinib is an investigational oral kinase inhibitor for the treatment of adult patients with myelofibrosis.

CEO: Adam R. Craig

Telephone: +1 206 282-7100

Address: 3101 Western Avenue, Seattle 98121, WA, US

Number of employees: 25

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

60%40%

Bearish Bullish

46%54%

Bearish Bullish

54%46%

TipRanks News for CTIC

Tue, 09 Aug 2022 05:10 GMT Analysts Are Bullish on These Healthcare Stocks: CTI BioPharma (CTIC), Cormedix (CRMD)

- TipRanks. All rights reserved.

Tue, 09 Aug 2022 05:01 GMT Analysts Offer Insights on Healthcare Companies: CTI BioPharma (CTIC) and Cormedix (CRMD)

- TipRanks. All rights reserved.

Tue, 09 Aug 2022 00:10 GMT Analysts Offer Insights on Healthcare Companies: CTI BioPharma (CTIC) and Establishment Labs Holdings (ESTA)

- TipRanks. All rights reserved.

Tue, 14 Jun 2022 02:05 GMT Analysts Offer Insights on Healthcare Companies: CTI BioPharma (CTIC) and Turning Point Therapeutics (TPTX)

- TipRanks. All rights reserved.

Sun, 05 Jun 2022 02:55 GMT Brookline Capital Markets Believes CTI BioPharma (CTIC) Still Has Room to Grow

- TipRanks. All rights reserved.

Fri, 27 May 2022 15:05 GMT Analysts Are Bullish on Top Healthcare Stocks: CTI BioPharma (CTIC), PDS Biotechnology (PDSB)

- TipRanks. All rights reserved.

Mon, 16 May 2022 04:26 GMT CTI BioPharma (CTIC) Receives a Buy from JMP Securities

- TipRanks. All rights reserved.

Fri, 13 May 2022 10:35 GMT Analysts Have Conflicting Sentiments on These Healthcare Companies: CTI BioPharma (CTIC), Dyadic International (DYAI) and Assembly Biosciences (ASMB)

- TipRanks. All rights reserved.

Thu, 12 May 2022 23:55 GMT CTI BioPharma (CTIC) Gets a Buy Rating from Brookline Capital Markets

- TipRanks. All rights reserved.

Fri, 15 Apr 2022 00:05 GMT CTI BioPharma (CTIC) Received its Third Buy in a Row

- TipRanks. All rights reserved.

Thu, 14 Apr 2022 12:15 GMT Needham Believes CTI BioPharma (CTIC) Wont Stop Here

- TipRanks. All rights reserved.

Thu, 14 Apr 2022 09:15 GMT Analysts Are Bullish on Top Healthcare Stocks: CTI BioPharma (CTIC), Oncternal Therapeutics (ONCT)

- TipRanks. All rights reserved.

Tue, 05 Apr 2022 01:45 GMT JMP Securities Believes CTI BioPharma (CTIC) Still Has Room to Grow

- TipRanks. All rights reserved.

Fri, 01 Apr 2022 10:36 GMT Needham Believes CTI BioPharma (CTIC) Still Has Room to Grow

- TipRanks. All rights reserved.

Fri, 01 Apr 2022 03:25 GMT BTIG Believes CTI BioPharma (CTIC) Wont Stop Here

- TipRanks. All rights reserved.

Fri, 01 Apr 2022 00:15 GMT Brookline Capital Markets Believes CTI BioPharma (CTIC) Wont Stop Here

- TipRanks. All rights reserved.

Thu, 24 Mar 2022 15:25 GMT Analysts Top Healthcare Picks: CTI BioPharma (CTIC), Mustang Bio (MBIO)

- TipRanks. All rights reserved.

Wed, 02 Mar 2022 05:35 GMT Analysts Are Bullish on Top Healthcare Stocks: CTI BioPharma (CTIC), Enanta Pharmaceuticals (ENTA)

- TipRanks. All rights reserved.

Tue, 01 Mar 2022 17:45 GMT CTI BioPharma (CTIC) Gets a Buy Rating from Needham

- TipRanks. All rights reserved.

News

Stocktwits